Home
Conditions
Histiocytosis

Clinical trial condition

Histiocytosis

Explore clinical trials studying Histiocytosis. Study availability and eligibility vary by location and protocol.

396 public trials 79 recruiting studies

Refine in advanced search Browse all conditions

Histiocytosis trial results

Not Yet Recruiting

A Study Comparing C Pola R-CHP+X With CR-CHOP in the Treatment of Previously Untreated DEL Under the Guidance of Genotyping

NCT07511114

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Double Expressor Lymphoma, +6 more
Locations: No. 197 Ruijin 2nd Road, Huangpu District, Shanghai, Shanghai, Shanghai Shanghai, China

View Trial Details

Not Yet Recruiting

Real-World Effectiveness and Safety of Glofitamab in Primary Refractory and Early Relapsed Diffuse Large B-Cell Lymphoma

NCT07472621

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Henan cancer hospital Zhengzhou, Henan, China

View Trial Details

Not Yet Recruiting

DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

NCT07440290

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +77 more
Locations: Belfast City Hospital Belfast, United Kingdom

University Hospital Birmingham Birmingham, United Kingdom

Birmingham Children's Hospital Birmingham, United Kingdom

Bristol Royal Hospital for Children Bristol, United Kingdom

View all 27 locations

View Trial Details

Not Yet Recruiting

Modified R-MINE Regimen vs. R-GemOx Regimens on the Treatment of Late Relapsed DLBCL

NCT07389356

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Glofitamab Combined With CAR-T Therapy in R/R DLBCL

NCT07326371

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma

NCT07231250

Conditions: Bispecific Antibody, Chemo-free Therapy, DLBCL - Diffuse Large B Cell Lymphoma, +7 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Not Yet Recruiting

ImmunoMRI for Assessment of Tumor-associated Macrophages

NCT07066436

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: Medical University of Vienna Vienna, State of Vienna, Austria

View Trial Details

Not Yet Recruiting

A Phase II Trial of 4 vs 6 Cycles of CHP Combined With Polatuzumab Vedotin-Rituximab in Untreated DLBCL Patients With IPI 0-1

NCT07034508

Conditions: DLBCL - Diffuse Large B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Hemic and Lymphatic Diseases, +5 more
Locations: China Institute of Hematology and Blood Diseases Hospital Tianjin, China

View Trial Details

Not Yet Recruiting

National Multicentre Study of the Natural History of Acid Sphingo-myelinase Deficiency in Adults and Children

NCT06985212

Conditions: Acid Sphingomyelinase Deficiency (ASMD), Brain Diseases, Brain Diseases, Metabolic, +20 more
Locations: Groupe Hospitalier Diaconesses Croix Saint-Simon Paris, France

View Trial Details

Not Yet Recruiting

Study of the Prevalence of Acid Sphingomyelinase Deficiency/Niemann Pick AB and B Disease in Patients With Diffuse Interstitial Lung Disease

NCT06869499

Conditions: Blood Platelet Disorders, Brain Diseases, Brain Diseases, Metabolic, +33 more
Locations: Groupe Hospitalier Diaconesses Croix Saint-Simon Paris, France

View Trial Details

Histiocytosis

Histiocytosis trial results

Related conditions